BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/09/2016

FDA Announces Public Meeting to Discuss Generic Drug User Fee Reauthorization

The FDA is hosting a public meeting to gather feedback on proposed recommendations for reauthorizing the Generic Drug User Fee Amendments of 2012, which authorize the collection of fees for generic drug reviews and inspections, set to expire at the end of September 2017.

Source: Federal Register — Food and Drug AdministrationOpen original release →